Iradimed (IRMD) Non-Current Deffered Revenue (2013 - 2026)

Iradimed (IRMD) has reported Non-Current Deffered Revenue for 14 consecutive years, with $4.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non-Current Deffered Revenue rose 21.95% year-over-year to $4.1 million in Q2 2026; TTM through Jun 2026 was $4.1 million, a 21.95% increase from a year earlier, with the FY2025 full-year figure at $4.0 million, up 32.91% from the prior year.
• Non-Current Deffered Revenue was $4.1 million for Q2 2026 at Iradimed, up from $3.8 million in the prior quarter.
• Over five years, Non-Current Deffered Revenue peaked at $4.1 million in Q2 2026 and troughed at $1.4 million in Q4 2022.
• A 5-year average of $2.9 million and a median of $2.9 million in 2024 frame the typical range for Non-Current Deffered Revenue.
• Across the five-year window, Non-Current Deffered Revenue decreased 29.82% in 2022 and jumped 103.14% in 2023, its largest moves.
• Over 5 years, Non-Current Deffered Revenue stood at $1.4 million in 2022, then jumped by 103.14% to $2.8 million in 2023, then grew by 7.14% to $3.0 million in 2024, then jumped by 32.91% to $4.0 million in 2025, then grew by 2.14% to $4.1 million in 2026.
• The last three Non-Current Deffered Revenue figures came in at $4.1 million (Q2 2026), $3.8 million (Q1 2026), and $4.0 million (Q4 2025), per Business Quant data.